PRKCE and neoplasm: Interestingly, inhibition of proliferation and cell cycle arrest associated with PKCε action has been reported in a number of contexts, in part linked to cell cycle inhibition associated with late G1 treatment with low doses of the tumour promoter PMA (Huang and Ives, 1987).